Atara Biotherapeutics
ATRA
ATRA
114 hedge funds and large institutions have $1.7B invested in Atara Biotherapeutics in 2018 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 50 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% more funds holding
Funds holding: 86 → 114 (+28)
0.59% more ownership
Funds ownership: 3.9% → 4.49% (+0.59%)
Holders
114
Holding in Top 10
3
Calls
$32.2M
Puts
$5.64M
Top Buyers
| 1 | +$170M | |
| 2 | +$66M | |
| 3 | +$61M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$55.4M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$42.2M |
Top Sellers
| 1 | -$66.8M | |
| 2 | -$10.1M | |
| 3 | -$8.58M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$5.26M |
| 5 |
NC
Nexthera Capital
New York
|
-$5.19M |